Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by smush74on Mar 17, 2015 1:22pm
77 Views
Post# 23530166

RE:RE:Cipher should start an Absorica price war to Incr profit$

RE:RE:Cipher should start an Absorica price war to Incr profit$ Do you know marketing?

1--Production costs, do you know how much R&D goes into developing an approved drug? Do you even know the process and capital required to adjust doses to be effective. The costs have to be recuperated, not to mention that its a time consuming and again takes $$$ They also have a time frame to get those R&D costs back.

2--Fixed costs do you think with a flip of a switch manufacturing a new dose size has no impact.

3-- do you have a link that it costs them .50 to make the pills.

4-- If the patent is safe for the forseable future why in you own word would you lower the costs of the "best in class" medication"

5-- Why start a production war when you are the best and let your standards fall (Ferrari vs Fiat). They are gaining market share, maybe not as fast as you want but at the rate the market wants

6-- Do you even know how desperate it sounds if you have the "best in class" and have to lower your price. If Cipher can lower their price the same can be said of their competitors, so now you have a race to the bottom which is not helpful for anyone.

7--So you know that for certain that that with a flip of a switch a whole new line can be swithched?  Have you ever visited a plant. You don't flip a switch and start making a new pill. Machines have to be shut down, sterilized, new formula programed with new ingerdients pass inspection. (remember their recent closures)

8--you want a good example use Viagra, they were first to market two other joined shortly after, not once did they lower their price until the patent expired I believe it was last year. Once that happened they then lowered their price to generic version. That is how it works, you don't cheapen your "best in class" at the beginning of its life cycle, you do it at the end.

9--even the generic version when it will appear will not be a 100% identical version.

Starting a price war is not in the interest of anybody, it sounds of desperation and when you have "the best in class" that is not the perception you want. Plus there are other consequences.

Lastly no I'm not styless, I have owned Cipher since it went public, the ups and downs, their first FDA refusal and all. I just don't get all emotional when people state there opinions whether they like the company or not. I don't really care nor does a public board influence my decisions.
Bullboard Posts